Roselene M. Alexis – Trademark Portfolio

Entity Type: 01

Roselene M. Alexis holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include EFIKAS and EFIKAS LAW. The owner is based in Houston, TX.

11715 Leclerc Lane

Houston, TX 77077

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EFIKAS
EFIKAS
Registered 2020

Trademark Classifications

Roselene M. Alexis's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

45
Legal & Security Services (1 filing)

Legal services; security services for the protection of property and individuals

Frequently Asked Questions

How many trademarks does Roselene M. Alexis have?

Roselene M. Alexis has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Roselene M. Alexis file in?

Roselene M. Alexis files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 45 (Legal & Security Services). Class 35 covers advertising; business management; business administration; office functions.

What are Roselene M. Alexis's most well-known trademarks?

Roselene M. Alexis's registered trademark portfolio includes well-known marks such as EFIKAS and EFIKAS LAW. These are among 2 currently registered trademarks in the portfolio.

What is Roselene M. Alexis's trademark registration success rate?

Roselene M. Alexis has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.